FDA To Bolster Post-Approval Drug Oversight

Law360, New York (February 27, 2008, 12:00 AM EST) -- In the wake of a rash of recent drug recalls, the U.S. Food and Drug Administration reportedly is set to keep a closer eye on the use of medicines after they have reached the market, marking a shift from its traditional focus on pre-approval monitoring of new treatments.

The agency said it would start monitoring the use of medicines after they have been approved, as part of a larger safety initiative announced to staffers Tuesday, the Associated Press reported.

Under the new initiative, the FDA will...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.